SC
MRNA icon

Steven Cohen’s Moderna MRNA Stock Holding History

Steven Cohen’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.89M Buy
98,400
+28,100
+40% +$1.45M 0.01% 1543
2026
Q1 		$3.57M Sell
70,300
-52,200
-43% -$2.44M ﹤0.01% 1921
2025
Q4 		$3.61M Sell
122,500
-2,468,200
-95% -$67.1M ﹤0.01% 2071
2025
Q3 		$66.9M Buy
+2,590,700
New +$72.3M 0.11% 204
2021
Q1 		– Sell
-350,000
Closed -$36.6M – 1098
2020
Q4 		$36.6M Buy
350,000
+275,000
+367% +$27.8M 0.18% 147
2020
Q3 		$5.31M Buy
+75,000
New +$5.23M 0.03% 545

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Steven Cohen's MRNA Position: Q2 2026 in Review

Steven Cohen sold out of Moderna (MRNA) in Q2 2026, closing a stake of 197,844 shares — an estimated $10.2M sold.

Steven Cohen first reported a position in MRNA in Q4 2018 and held it in 2 quarters. The position peaked at $10.1M in Q1 2026. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Steven Cohen reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 197,844 Moderna shares in Q2 2026, an estimated $10.2M.
  • Steven Cohen first reported a position in Moderna in Q4 2018 and held it in 2 quarters.
  • Steven Cohen's Moderna position peaked at $10.1M in Q1 2026.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.